Imaging of prion diseases

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 5, 2012, Pages 998-1012

  Letourneau Guillon, Laurent ^a   Wada, Ryan ^b   Kucharczyk, Walter ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Radiology Consultants Associated   (Canada)

Author keywords

Creutzfeldt Jakob disease; Dementia; Diffusion weighted imaging; MRI; Prion

Indexed keywords

CLINICAL FEATURE; CLINICAL PRACTICE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; HUMAN; LETHALITY; MOLECULAR IMAGING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; PRION DISEASES;

EID: 84859793002     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23504     Document Type: Review

References (100)

1. Brown K, Mastrianni JA. The prion diseases. J Geriatr Psychiatry Neurol 2010;23:277-298.
2. Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, Jager HR. Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry 2007;78:664-670. (Pubitemid 46998832)
3. du Plessis DG. Prion protein disease and neuropathology of prion disease. Neuroimaging Clin N Am 2008;18:163-182; ix.
4. Parchi P, Strammiello R, Notari S, et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 2009;118:659-671.
5. Okamura N, Shiga Y, Furumoto S, et al. In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET. Eur J Nucl Med Mol Imaging 2010;37:934-941.
6. Meissner B, Kallenberg K, Sanchez-Juan P, et al. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 2009;72:1994-2001.
7. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-233. (Pubitemid 29382879)
8. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004;63:443-449. (Pubitemid 39031372)
9. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 2005;26:1551-1562. (Pubitemid 43733460)
10. Lodi R, Parchi P, Tonon C, et al. Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain 2009;132(Pt 10):2669-2679.
11. Galanaud D, Haik S, Linguraru MG, et al. Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases. AJNR Am J Neuroradiol 2010;31:1311-1318.
12. Lee H, Hoffman C, Kingsley PB, Degnan A, Cohen O, Prohovnik I. Enhanced detection of diffusion reductions in Creutzfeldt-Jakob disease at a higher B factor. AJNR Am J Neuroradiol 2010;31:49-54.
13. Bahn MM, Parchi P. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. Arch Neurol 1999;56:577-583. (Pubitemid 29218153)
14. Manners DN, Parchi P, Tonon C, et al. Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease. Neurology 2009;72:1425-1431.
15. Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J. Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease. Arch Neurol 2002;59:128-134. (Pubitemid 34052565)
16. Ukisu R, Kushihashi T, Tanaka E, et al. Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations. Radiographics 2006;26(Suppl 1):S191-S204.
17. Ukisu R, Kushihashi T, Kitanosono T, et al. Serial diffusion-weighted MRI of Creutzfeldt-Jakob disease. AJR Am J Roentgenol 2005;184:560-566. (Pubitemid 46657267)
18. Matoba M, Tonami H, Miyaji H, Yokota H, Yamamoto I. Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI. J Comput Assist Tomogr 2001;25:274-277. (Pubitemid 32222896)
19. Haik S, Galanaud D, Linguraru MG, et al. In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia. Arch Neurol 2008;65:545-549. (Pubitemid 351549967)
20. Haik S, Dormont D, Faucheux BA, Marsault C, Hauw JJ. Prion protein deposits match magnetic resonance imaging signal abnormalities in Creutzfeldt-Jakob disease. Ann Neurol 2002;51:797-799. (Pubitemid 34568867)
21. Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L. MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 1998;40:65-70. (Pubitemid 28438795)
22. Zhang WJ, Westover MB, Keary CJ. Premortem diagnosis of sporadic Creutzfeldt-Jakob Disease aided by positron-emission tomography imaging. AJNR Am J Neuroradiol 2011;32:E18.
23. Henkel K, Zerr I, Hertel A, et al. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol 2002;249:699-705. (Pubitemid 34651751)
24. Engler H, Lundberg PO, Ekbom K, et al. Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease. Eur J Nucl Med Mol Imaging 2003;30:85-95. (Pubitemid 36692897)
25. Villemagne VL, McLean CA, Reardon K, et al. 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2009;80:998-1001.
26. Will RG, Matthews WB. A retrospective study of Creutzfeldt- Jakob disease in England and Wales 1970-79. I. Clinical features. J Neurol Neurosurg Psychiatry 1984;47:134-140. (Pubitemid 14154718)
27. Cornelius JR, Boes CJ, Ghearing G, Leavitt JA, Kumar N. Visual symptoms in the Heidenhain variant of Creutzfeldt-Jakob Disease. J Neuroimaging 2009;19:283-287.
28. Keyrouz SG, Labib BT, Sethi R. MRI and EEG findings in Heidenhain variant of Creutzfeldt-Jakob disease. Neurology 2006;67:333. (Pubitemid 44305429)
29. Zerr I, Schulz-Schaeffer WJ, Giese A, et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000;48:323-329.
30. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004;56:702-708. (Pubitemid 39540751)
31. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009;132(Pt 10):2659-2668.
32. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-815.
33. Collins SJ, Sanchez-Juan P, Masters CL, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006;129(Pt 9):2278-2287. (Pubitemid 44522114)
34. Chohan G, Pennington C, Mackenzie JM, et al. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 2010;81:1243-1248.
35. Collins SJ, McGlade A, Boyd A, Masters CL, Klug GM. 14-3-3 protein detection and sporadic CJD: the status quo serves well while awaiting progress. J Neurol Neurosurg Psychiatry 2010;81:1181.
36. Hernandez Echebarria LE, Saiz A, Graus F, et al. Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy. Neurology 2000;54:1539-1540. (Pubitemid 30210486)
37. Saiz A, Graus F, Dalmau J, Pifarre A, Marin C, Tolosa E. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 1999;46:774-777. (Pubitemid 29518140)
38. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40. (Pubitemid 28124646)
39. Meissner B, Kallenberg K, Sanchez-Juan P, et al. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 2008;29:1519-1524.
40. Tian HJ, Zhang JT, Lang SY, Wang XQ. MRI sequence findings in sporadic Creutzfeldt-Jakob disease. J Clin Neurosci 2010;17:1378-1380.
41. Uchino A, Yoshinaga M, Shiokawa O, Hata H, Ohno M. Serial MR imaging in Creutzfeldt-Jakob disease. Neuroradiology 1991;33:364-367.
42. Lin YR, Young GS, Chen NK, Dillon WP, Wong S. Creutzfeldt-jakob disease involvement of rolandic cortex: a quantitative apparent diffusion coefficient evaluation. AJNR Am J Neuroradiol 2006;27:1755-1759. (Pubitemid 44413566)
43. Meissner B, Kortner K, Bartl M, et al. Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings. Neurology 2004;63:450-456. (Pubitemid 39031373)
44. Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, et al. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. Brain 2006;129(Pt 9):2288-2296. (Pubitemid 44522115)
45. Summers DM, Collie DA, Zeidler M, Will RG. The pulvinar sign in variant Creutzfeldt-Jakob disease. Arch Neurol 2004;61:446-447. (Pubitemid 38327368)
46. Rossetti AO, Bogousslavsky J, Glatzel M, Aguzzi A. Mimicry of variant Creutzfeldt-Jakob disease by sporadic Creutzfeldt-Jakob disease: importance of the pulvinar sign. Arch Neurol 2004;61:445-446. (Pubitemid 38327367)
47. Petzold GC, Westner I, Bohner G, Einhaupl KM, Kretzschmar HA, Valdueza JM. False-positive pulvinar sign on MRI in sporadic Creutzfeldt-Jakob disease. Neurology 2004;62:1235-1236. (Pubitemid 38456536)
48. Haik S, Brandel JP, Oppenheim C, et al. Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology 2002;58:148-149. (Pubitemid 34041959)
49. Martindale J, Geschwind MD, De Armond S, et al. Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. Arch Neurol 2003;60:767-770. (Pubitemid 36569898)
50. Brandel JP, Galanaud D, Freeman L, Laplanche JL, Haik S. Variant or sporadic Creutzfeldt-Jakob disease? Lancet 2010;375:889; author reply 889-890.
51. de Priester JA, Jansen GH, de Kruijk JR, Wilmink JT. New MRI findings in Creutzfeldt-Jakob disease: high signal in the globus pallidus on T1-weighted images. Neuroradiology 1999;41:265-268. (Pubitemid 29195261)
52. Matsusue E, Kinoshita T, Sugihara S, Fujii S, Ogawa T, Ohama E. White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations. AJNR Am J Neuroradiol 2004;25:910-918. (Pubitemid 38765866)
53. Poon MA, Stuckey S, Storey E. MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt-Jakob disease. Neuroradiology 2001;43:746-749. (Pubitemid 32894378)
54. Pandya HG, Coley SC, Wilkinson ID, Griffiths PD. Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease. Clin Radiol 2003;58:148-153. (Pubitemid 36221676)
55. Krasnianski A, Kallenberg K, Collie DA, et al. MRI in the classical MM1 and the atypical MV2 subtypes of sporadic CJD: an inter-observer agreement study. Eur J Neurol 2008;15:762-771.
56. Krasnianski A, Meissner B, Schulz-Schaeffer W, et al. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006;63:876-880. (Pubitemid 43882297)
57. Meissner B, Westner IM, Kallenberg K, et al. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005;65:1544-1550. (Pubitemid 41689466)
58. Hamaguchi T, Kitamoto T, Sato T, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 2005;64:643-648. (Pubitemid 40261892)
59. Fukushima R, Shiga Y, Nakamura M, Fujimori J, Kitamoto T, Yoshida Y. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan. J Neurol Neurosurg Psychiatry 2004;75:485-487. (Pubitemid 38338785)
60. Zeidler M, Stewart GE, Barraclough CR, et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997;350:903-907. (Pubitemid 27420525)
61. Kaski D, Mead S, Hyare H, et al. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009;374:2128.
62. Collie DA, Summers DM, Sellar RJ, et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 2003;24:1560-1569. (Pubitemid 37151720)
63. Zeidler M, Sellar RJ, Collie DA, et al. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000;355:1412-1418. (Pubitemid 30215964)
64. Mihara M, Sugase S, Konaka K, et al. The "pulvinar sign" in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin's lymphoma. J Neurol Neurosurg Psychiatry 2005;76:882-884. (Pubitemid 40805826)
65. Schmidt C, Plickert S, Summers D, Zerr I. Pulvinar sign in Wernicke's encephalopathy. CNS Spectr 2010;15:215-218.
66. Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006;67:389-393. (Pubitemid 44214958)
67. Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain 2010;133:3043-3057.
68. Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, et al. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease. Neurology 2007;69:360-367. (Pubitemid 47205663)
69. Lewis AM, Yu M, DeArmond SJ, Dillon WP, Miller BL, Geschwind MD. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Arch Neurol 2006;63:288-290. (Pubitemid 43261744)
70. Rabinstein AA, Whiteman ML, Shebert RT. Abnormal diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease following corneal transplantations. Arch Neurol 2002;59:637-639. (Pubitemid 34289970)
71. Meissner B, Kallenberg K, Sanchez-Juan P, et al. MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease. J Neurol 2009;256:355-363.
72. Kovacs GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet 2005;118:166-174. (Pubitemid 41672078)
73. Fulbright RK, Hoffmann C, Lee H, Pozamantir A, Chapman J, Prohovnik I. MR imaging of familial Creutzfeldt-Jakob disease: a blinded and controlled study. AJNR Am J Neuroradiol 2008;29:1638-1643.
74. Nitrini R, Mendonca RA, Huang N, LeBlanc A, Livramento JA, Marie SK. Diffusion-weighted MRI in two cases of familial Creutzfeldt-Jakob disease. J Neurol Sci 2001;184:163-167. (Pubitemid 32178270)
75. Yang TI, Jung DS, Ahn BY, et al. Familial Creutzfeldt-Jakob disease with V180I mutation. J Korean Med Sci 2010;25:1097-1100.
76. Kono S, Manabe Y, Fujii D, et al. Serial diffusion-weighted MRI and SPECT findings in a Creutzfeldt-Jakob disease patient with V180I mutation. J Neurol Sci 2011;301:100-103.
77. Tsuboi Y, Baba Y, Doh-ura K, Imamura A, Fujioka S, Yamada T. Diffusion-weighted MRI in familial Creutzfeldt-Jakob disease with the codon 200 mutation in the prion protein gene. J Neurol Sci 2005;232:45-49. (Pubitemid 40585841)
78. Clerici F, Elia A, Girotti F, et al. Atypical presentation of Creutzfeldt-Jakob disease: the first Italian case associated with E196K mutation in the PRNP gene. J Neurol Sci 2008;275:145-147.
79. Seror I, Lee H, Cohen OS, Hoffmann C, Prohovnik I. Putaminal volume and diffusion in early familial Creutzfeldt-Jakob disease. J Neurol Sci 2010;288:129-134.
80. Liu Z, Jia L, Piao Y, et al. Creutzfeldt-Jakob disease with PRNP G114V mutation in a Chinese family. Acta Neurol Scand 2010;121:377-383.
81. Waldman AD, Cordery RJ, MacManus DG, Godbolt A, Collinge J, Rossor MN. Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy. Neuroradiology 2006;48:428-433. (Pubitemid 43923167)
82. Aralasmak A, Crain BJ, Zou WQ, Yousem DM. A prion disease-possible Gerstmann-Straussler-Scheinker disease: a case report. J Comput Assist Tomogr 2006;30:135-139. (Pubitemid 43052314)
83. Arata H, Takashima H, Hirano R, et al. Early clinical signs and imaging findings in Gerstmann-Straussler-Scheinker syndrome (Pro102Leu). Neurology 2006;66:1672-1678. (Pubitemid 43964621)
84. Konaka K, Kaido M, Okuda Y, et al. Proton magnetic resonance spectroscopy of a patient with Gerstmann-Straussler-Scheinker disease. Neuroradiology 2000;42:662-665.
85. Yamamoto S, Kinoshita M, Furukawa S, Kajiyama K. Early abnormality of diffusion-weighted magnetic resonance imaging followed by brain atrophy in a case of Gerstmann-Straussler-Scheinker disease. Arch Neurol 2007;64:450-451. (Pubitemid 46425707)
86. Irisawa M, Amanuma M, Kozawa E, Kimura F, Araki N. A case of Gerstmann-Straussler-Scheinker syndrome. Magn Reson Med Sci 2007;6:53-57.
87. Park MJ, Jo HY, Cheon SM, Choi SS, Kim YS, Kim JW. A case of gerstmann-straussler-scheinker disease. J Clin Neurol 2010;6:46-50.
88. Kepe V, Ghetti B, Farlow MR, et al. PET of brain prion protein amyloid in Gerstmann-Straussler-Scheinker disease. Brain Pathol 2010;20:419-430.
89. Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 1995;5:43-51.
90. Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol 2003;2:167-176. (Pubitemid 37443320)
91. Hirai T, Korogi Y, Yoshizumi K, Shigematsu Y, Sugahara T, Takahashi M. Limbic lobe of the human brain: evaluation with turbo fluid-attenuated inversion-recovery MR imaging. Radiology 2000;215:470-475. (Pubitemid 30237847)
92. Sarma D, Farb RI, Mikulis DJ, terBrugge KG. Reversal of restricted diffusion in cerebral venous thrombosis: case report. Neuroradiology 2004;46:118-121. (Pubitemid 38396953)
93. Hegde AN, Mohan S, Lath N, Lim CC. Differential diagnosis for bilateral abnormalities of the Basal Ganglia and thalamus. Radiographics 2011;31:5-30.
94. Kang EG, Jeon SJ, Choi SS, Song CJ, Yu IK. Diffusion MR imaging of hypoglycemic encephalopathy. AJNR Am J Neuroradiol 2010;31:559-564.
95. U-King-Im JM, Yu E, Bartlett E, Soobrah R, Kucharczyk W. Acute hyperammonemic encephalopathy in adults: imaging findings. AJNR Am J Neuroradiol 2011;32:413-418.
96. Santos Andrade C, Tavares Lucato L, da Graca Morais Martin M, et al. Non-alcoholic Wernicke's encephalopathy: broadening the clinicoradiological spectrum. Br J Radiol 2010; 83:437-446.
97. Dehdashti AR, Matouk CC, Terbrugge K, Wallace MC, Willinsky RA. Clues to dural arteriovenous fistulas in patients with progressive dementia. Can J Neurol Sci 2010;37:532-534.
98. Goncalves MB, Maia O Jr, Correa JL, Siqueira SB, Christoph Dde H, Landeiro JA. Dural arteriovenous fistula presenting as thalamic dementia. Arq Neuropsiquiatr 2008;66:264-267. (Pubitemid 351883918)
99. Yamamoto T, Watanabe M, Miura A, Hirahara T, Hirano T, Uchino M. [A case of dural arteriovenous fistula associated with bilateral thalamic lesions]. Rinsho Shinkeigaku 2010;50:718-724.
100. Heath CA, Cooper SA, Murray K, et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol 2010;67:761-770.